dr. agarwal on the combination of lenvatinib and everolimus in mrcc
Published 5 years ago • 1.7K plays • Length 1:31Download video MP4
Download video MP3
Similar videos
-
3:39
managing patients on lenvatinib/everolimus in mrcc
-
3:42
lenvatinib and everolimus in relapsed/refractory mrcc
-
6:42
the role of lenvatinib in advanced rcc
-
0:45
dr. choueiri on fda approval of lenvatinib/everolimus in rcc
-
5:32
lenvatinib and everolimus for advanced rcc
-
1:14
dr. larkin on lenvatinib plus everolimus in patients with rcc
-
2:51
practical experience with lenvatinib/everolimus in rcc
-
4:27
lenvatinib in renal cell carcinoma
-
2:37
lenvatinib/everolimus in refractory mrcc
-
2:40
efficacy and safety of lenvatinib/everolimus in mrcc
-
0:53
dr. agarwal on emerging immunotherapeutic combinations in kidney cancer
-
1:19
dr. agarwal on the safety of cabozantinib/atezolizumab in mcrpc
-
4:05
lenvatinib increases progression free survival with everolimus in metastatic renal cell carcinoma
-
6:22
mtor/tki combination therapy in kidney cancer
-
1:32
three-arm trial of lenvatinib and everolimus for metastatic renal cell carcinoma
-
2:13
dr. hutson on lenvatinib/everolimus combo in rcc
-
3:29
other emerging combination approaches in rcc
-
1:06
dr. agarwal on the checkmate-214 trial for kidney cancer
-
1:19
phase 2 trial of lenvatinib and everolimus for metastatic renal cell carcinoma